JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peabody, D. S.
Right arrow Articles by Chakerian, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peabody, D. S.
Right arrow Articles by Chakerian, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 36, 25403-25410, September 3, 1999


Asymmetric Contributions to RNA Binding by the Thr45 Residues of the MS2 Coat Protein Dimer*

David S. PeabodyDagger and Artemis Chakerian

From the Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

A prominent feature of the interaction of MS2 coat protein with RNA is the quasi-symmetric insertion of a bulged adenine (A-10) and a loop adenine (A-4) into conserved pockets on each subunit of the coat protein dimer. Because of its presence in both of these adenine-binding pockets, Thr45 is thought to play an important role in interaction with RNA on both subunits of the dimer. To test the significance of Thr45, we introduced all 19 amino acid substitutions. However, we were initially unable to determine the effects of the mutations on RNA binding because every substitution compromised the ability of coat protein to fold correctly. Genetic fusion of coat protein subunits reverted these protein structural defects, allowing us to show that the RNA binding activity of coat protein tolerates substitution of Thr45, but only on one or the other subunit of the dimer. Single-chain heterodimer complementation experiments suggest that the primary site of Thr45 interaction with RNA is with A-4 in the translational operator. Either contact of Thr45 with A-10 makes little contribution to stability of the RNA-protein complex, or the effects of Thr45 substitution are offset by conformational adjustments that introduce new, favorable contacts at nearby sites.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The coat protein of bacteriophage MS2 is a symmetric dimer that serves both as the major structural protein of the virus particle and as a repressor of viral replicase translation. Structural analyses of coat protein (1-3) and of its RNA target (4), together with detailed genetic and biochemical dissection of its RNA binding function (5-10), have made this one of the best understood examples of RNA binding by a protein. The structure of the binding site for coat protein is shown in Fig. 1A. In the RNA-protein complex, the bulged A at position -10 and the loop A at -4 project outward from the body of the RNA, with the planes of the two bases aligned roughly parallel to the helix axis. A-4 and A-10 form quasi-symmetric contacts with coat protein, inserting themselves into pockets comprised of Val29, Thr45, Ser47, and Lys61 on different subunits of the dimer. Because operator RNA is asymmetric, so too is the RNA-protein complex and we may distinguish the two subunits of the dimer. Here we use the convention of Valegard (11, 12), calling the the two subunits A and B. Inspection of the crystal structure of the RNA-protein complex suggests that ThrA45 makes H-bonds with N6 and N7 of A-4, while on the other subunit ThrB45 seems to H-bond with N1 and N6 of A-10. However, it is difficult to predict reliably the separate contributions of these individual interactions to binding energy on structural grounds alone.

We previously mapped genetically the MS2 RNA-binding site by isolating a series of repressor-defective mutants in which the ability to bind operator RNA was reduced (7). These mutants were isolated using a two-plasmid genetic system in which coat protein expressed from one plasmid represses translation of a replicase-beta -galactosidase fusion expressed from a second plasmid. Repressor-defective mutants make blue colonies on plates containing the chromogenic beta -galactosidase substrate 5-bromo-4-chloro-3-indolyl-beta -D-galactoside (X-gal).1 To ensure that these mutational defects were confined to the RNA-binding site, each mutant was screened for the ability to assemble into a virus-like particle. This allowed us to discard mutants having gross perturbations of protein structure. In this manner, we identified 10 different amino acids, each residing on the surface of the coat protein beta -sheet, whose substitution specifically disrupted RNA binding activity (Fig. 1B). Given the apparent importance of Thr45 in RNA binding, however, we were surprised by the absence of substitutions identifying Thr45 as a binding site residue. Here we describe the introduction of all 19 amino acid substitutions at position 45. Unexpectedly, every mutation reduced the ability of coat protein to fold correctly, apparently explaining our initial failure to find repressor-defective, assembly-competent Thr45 substitutions. At first, this frustrated our efforts to determine the effects of the mutations on RNA binding, but genetic fusion of coat protein subunits reverted these structural defects and allowed investigation of the RNA-binding role of Thr45.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 1.   A, structure of the MS2 translational operator. Note the adenosines at -4 and -10. B, a schematic illustration of the RNA-binding site of MS2 coat protein as defined by genetic analysis. Shaded circles identify the positions of amino acids whose substitution results in the repressor-defective phenotype. Because the coat protein dimer is symmetric and its RNA ligand is asymmetric, this is actually a composite picture of two overlapping binding sites. C, the heterodimer complementation map of the binding site. Here shaded circles represent a single asymmetric RNA binding site. The basis of heterodimer complementation is explained under "Results" and in Fig. 5.


    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Recombinant DNA-- The mutants described in this paper were constructed by site-directed mutagenesis using the method of Kunkel et al. (13) and are simple variants of pCT119 (6, 7). In all cases the complete nucleotide sequences of the mutant genes were determined. The single-chain dimer (i.e. subunit fusion) constructs were produced by methods described earlier (8), and incorporated the various mutations described in the text. Plasmids were introduced into Escherichia coli strain CSH41F- (14) for coat protein expression.

Protein Characterization-- To determine the relative amounts of coat protein accumulating in soluble form and as insoluble aggregates, cells from overnight 1-ml cultures were pelleted by centrifugation, resuspended in 0.25 ml of 100 mM NaCl, 0.1 mM MgSO4, 0.01 mM EDTA, 10 mM Tris-HCl, pH 7.5, and sonicated three times (on ice) for a total of 30 s. Insoluble material was then pelleted by centrifugation. Pellets were resuspended in 0.25 ml of the above buffer. Five µl of each supernatant or pellet fraction were combined with an equal volume of 2× SDS gel sample buffer, heated to 95 °C for 3 min, and applied to a 17.5% polyacrylamide gel containing SDS (15). The gel was electroblotted to Nytran (Schleicher & Schuell), and coat protein was visualized with anti-MS2 serum and 125I-labeled protein A (16).

The capacities of individual proteins to assemble into virus-like particles were assessed by agarose gel electrophoresis as follows. Cells from 1-ml overnight cultures were pelleted by centrifugation, resuspended in 0.25 ml of 100 mM NaCl, 0.1 mM MgSO4, 0.01 mM EDTA, 50 mM Tris-HCl, pH 7.5, and sonicated. After cellular debris was removed by centrifugation, 10 µl from each lysate were applied to a 1.0% agarose gel in 50 mM potassium phosphate, pH 7.0. Upon completion of electrophoresis, the gel was blotted to a Nytran membrane (Schleicher & Schuell) and coat protein was visualized using anti-MS2 serum and 125I-protein A (NEN Life Science Products).

Measuring Translational Repression-- The RNA binding activities of the coat protein variants were assessed by their abilities to repress translation of a replicase-beta -galactosidase fusion protein produced from pRZ5 in strain CSH41F- (see Ref. 6 for details). Cells containing the appropriate plasmids were streaked on LB plates containing X-gal and compared for relative blueness. Assay of beta -galactosidase was performed in triplicate by the method described by Miller (14). Activities are reported as percentages of the activity of an unrepressed control.

RNA Binding Assays-- Radioactive RNA was produced by the method of Draper et al (17). Protein-excess nitrocellulose filter-binding assays (18) were performed with [32P]RNA at a concentration of 10 pM, which was titrated with coat proteins purified as described by Peabody (6). Binding curves were fitted to a bimolecular equilibrium using the Kaleidagraph program from Abelbeck Software. The concentration of active coat protein in each preparation was determined in a similar filter-binding assay, but one in which 50 nM protein solutions were titrated with excess radioactive RNA.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Effects of Amino Acid Substitutions at Position 45 on the Structure and Translational Repressor Function of Coat Protein-- Using site-directed mutagenesis, codons for the 19 amino acid alternatives to threonine were introduced at position 45 in the coat sequence in plasmid pCT119. The effects of amino acid substitutions on RNA binding were monitored by a translational repression assay in which functional coat protein expressed from pCT119 represses the synthesis of a replicase-beta -galactosidase fusion protein expressed from pRZ5 (6). Thus, the extent of repression is conveniently determined by comparing the blueness of bacterial colonies on solid medium containing the chromogenic substrate X-gal. Table I lists the mutations and shows their effects on translational repression as judged by colony color. The beta -galactosidase activities of some mutants were determined using o-nitrophenyl-beta -D-galactoside as substrate (Table II). Every substitution resulted in a translational repressor defect. Most mutants showed little or no ability to repress translation. Even conservative substitutions showed significant loss of repressor activity. For example, replacing Thr45 with serine (T45S) resulted in a repressor defect.

                              
View this table:
[in this window]
[in a new window]
 
Table I
The translational repressor activities of wild-type (pCT119) and the Thr45 mutants as indicated by colony color on X-gal plates
Plasmid pUCter3 produces no coat protein and serves as the no-repressor control.

                              
View this table:
[in this window]
[in a new window]
 
Table II
The beta -galactosidase activities produced by selected mutants as single-chain homodimers or as heterodimers with wild-type
These values are percentages of the enzyme activity produced in the unrepressed case (pUCter3).

In order to conclude with confidence that an amino acid substitution directly disrupts the RNA binding site, it is necessary to exclude the alternative possibility that it grossly perturbs coat protein structure, affecting RNA binding activity only secondarily. This is readily accomplished by measuring the ability of coat protein to assemble into virus-like particles, a property that depends on proper protein folding and is easily monitored in an agarose gel electrophoretic assay (7). Virus-like particles possess a distinctive mobility and may be visualized with anti-MS2 serum and 125I-protein A after blotting to nitrocellulose. Fig. 2A shows that every amino acid substitution at position 45 reduced the yield of virus-like particles. All the mutants were significantly impaired in their abilities to produce capsids; about half were apparently completely defective for capsid synthesis. Since its location in the structure of coat protein indicates no direct role for Thr45 in the assembly of coat dimers into capsids, these results suggest that the mutant proteins fail to fold normally into the dimers that serve both as translational repressors and as the precursors to capsids.


View larger version (92K):
[in this window]
[in a new window]
 
Fig. 2.   A, agarose gel electrophoresis and Western blot of capsids produced by the WT and various T45 mutants (identified using the single-letter amino acid code). B, SDS-polyacrylamide gel electrophoresis and Western blot analysis of the coat proteins produced by WT and various T45 mutants (again denoted by the single-letter amino acid code). Cells were lysed by sonication and separated into soluble and insoluble fractions by centrifugation. In each pair of lanes, the one on the left is the soluble fraction, and the one on the right is the insoluble fraction.

As an additional test of the ability of mutant proteins to acquire native structure, we determined their intracellular fates. It is commonly observed that mutant proteins which fail to fold correctly are either degraded by proteolysis or accumulate as insoluble aggregates in inclusion bodies. Sonicated cell lysates were fractionated by centrifugation into soluble and insoluble fractions, which were then subjected to SDS gel electrophoresis and Western blotting. Coat proteins were visualized using anti-MS2 serum and 125I-protein A. Fig. 2B shows the results. Wild-type coat protein was found mostly in the soluble fraction, and this was also true of T45E, T45Q, T45K, and T45R. The remaining mutant coat proteins suffered the following fates. (i) T45P, T45N, T45D, T45F, T45G, T45H, and T45V showed little or no coat protein in either fraction and were apparently proteolytically degraded. (ii) In other cases (T45A, T45S, T45 M, T45Y, T45L, T45I, T45W, and T45C) coat protein was detected, but half or more was found in the insoluble fraction.

Genetic Fusion of Subunits of the Coat Protein Dimer Corrects the Structural Defects-- We reported previously the construction of p2CTdl-13, a plasmid in which the coat sequence is duplicated and the two sequences are joined together in a translational fusion (8). Because the N and C termini of different subunits are near each other in space, the single-chain "dimer" folds properly and possesses the RNA binding and capsid assembly functions typical of wild-type coat protein. This fused dimer possesses greatly increased resistance to denaturation by urea and corrects the structural defects imposed by certain peptide insertions (19) and temperature-sensitive mutations.2 Therefore, we wondered whether the defects conferred by the Thr45 substitutions might also be reverted by subunit fusion. We created genetic subunit fusions using a selection of mutants: T45P, T45N, T45V, T45A, T45S, T45L, and T45G. In addition to creating mutant homodimers, which we call 2T45P, 2T45N, etc., many of the mutant sequences were also paired with the wild-type in either the N- or C-terminal halves of the duplicated molecule. We call these, for example, WT-T45P when the mutant sequence is in the 3'-half of the fused dimer, and T45P-WT when it is in the 5'-half.

Tests for capsid assembly activity (Fig. 3A) and for production of soluble protein (Fig. 3B) showed that, with one exception, subunit fusion corrected the structural defects of these mutants. This was true whether a mutant was paired with itself in a fused homodimer, or with the wild-type sequence in either half of a fused heterodimer. In their single-chain forms, they were generally produced in normal amounts and in soluble form. They also assemble into virus-like particles, although in a few cases, namely WT-T45V, 2T45V, T45G-WT, and 2T45G, assembly activity was only partially restored (Fig. 3B). Therefore, subunit fusion promotes the formation of native coat protein structure. The one exception was T45P. Although subunit fusion rescued it from proteolysis so that the fused dimer derivatives (WT-T45P, T45P-WT, and 2T45P) were present in normal amounts, they were found almost entirely in the aggregated fraction, and no capsids were detected. The inability of subunit fusion to fully correct the T45P defect is consistent with the difficulty of incorporating prolines into beta -sheets.


View larger version (85K):
[in this window]
[in a new window]
 
Fig. 3.   A, agarose gel electrophoresis and Western blot analysis of capsids produced by the single-chain constructs. B, SDS-polyacrylamide gel electrophoresis and Western blot analysis of the soluble (the left lane in each pair) and aggregated (right lanes) coat proteins produced by the wild-type (2CT) and mutant (single-letter amino acid code) single-chain constructs.

The translational repressor activities of the proteins were assessed by assays of beta -galactosidase activity present in strains containing the appropriate plasmids (Table II). In most cases, subunit fusion apparently restored whatever degree of repressor activity had been lost due to folding defects, allowing us to distinguish the protein-structural and RNA-binding site effects of the amino acid substitutions. Although many mutants were still repressor-defective, others showed complete, or nearly complete, restoration of repressor activity. The WT-T45S and T45S-WT and the WT-T45G and T45G-WT heterodimer fusions repressed translation as well as wild-type, but with the 2T45S and 2T45G homodimers repressor activity was restored only incompletely. Three other mutants we tested (T45A, T45C, and T45N) were nearly as good repressors as wild-type when paired with the wild-type sequence in heterodimers, but, again, each was less active in mutant homodimers.

We also determined the RNA binding activities of some of the fused dimer variants in vitro by measuring their abilities to retain 32P-labeled MS2 operator RNA on nitrocellulose filters. The results shown in Fig. 4 indicate that the WT homodimer and the WT-T45S heterodimer were indistinguishable in their abilities to bind RNA, each giving dissociation constants of 1 nM. The 2T45S homodimer and the WT-T45G heterodimer each bound only a little less well than WT at approximately 2 nM. WT-T45A and 2T45A, the worst binders of the group, gave 3 and 4 nM dissociation constants respectively. We also attempted to determine the binding affinity of 2T45G, but were unable to reconstitute its binding activity after the acid denaturation step used in its purification (6). We assume this to be caused by a failure of this mutant to refold properly. The results of in vitro binding analyses roughly parallel the in vivo translational repression assays, although some of recombinants (e.g. 2T45A) seem to bind RNA better than might be expected from their relatively poor translational repressor activities.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 4.   Nitrocellulose filter-binding assays of the RNA binding activities of wild-type single-chain dimers and the indicated single-chain heterodimers. Dissociation constants are given within each panel.

Mapping the Site of Thr45 Interaction to A-4 or A-10-- The crystal structure of the coat protein-RNA complex suggests that the two Thr45 residues make contributions to RNA binding by interacting with A-4 and A-10 on different subunits of the dimer. However, the results described above indicate that one of the Thr45 residues is largely dispensable. Which of the two interactions is the important one? Structural analysis of the coat protein-RNA complex seems inconclusive on this point. On subunit A Thr45 is thought to make H-bonds with N6 and N7 of A-4, and on subunit B it is reputed to form similar interactions with N1 and N6 of A-10 (11, 12). However, it is not possible to predict reliably the contributions of these individual interactions to the energy of RNA binding on structural grounds alone. We sought to resolve this question genetically.

In solution coat protein is a symmetric dimer and therefore contains two binding sites for its asymmetric RNA ligand. Since the two sites overlap, only one can be occupied at any instant, accounting for the binding stoichiometry of one RNA per coat protein dimer. A bound RNA molecule makes contacts with both subunits of the dimer, so it is convenient to think of each binding site as being made up of two non-identical half-sites, each representing the contribution of one monomer to a complete binding site. We may label the half-sites of one binding site A and B, and those of the other site A' and B' (Fig. 5A). In the conventional homodimer, any amino acid substitution that inactivates a particular half-site does so on both monomers, thereby inactivating both complete binding sites (Fig. 5B). However, the ability to genetically fuse the two subunits of coat protein makes it possible to create single-chain heterodimers in which the two halves of the molecule may contain different combinations of mutant and wild-type sequences. When a mutation inactivating one half-site, say A, is paired in a heterodimer with a wild-type sequence, one intact, functional site is restored (Fig. 5C). Likewise, when a mutation inactivating one half-site (for example A) is paired with a mutation inactivating the other half-site (B), one binding site is doubly defective, but one functional site is produced (Fig. 5D). These heterodimers are competent to bind RNA. Of course, the heterodimerization of mutants with different lesions in the same half-site yields molecules nonfunctional for RNA binding. On the other hand, mutations affecting residues that play roles in both half-sites are not complementable by any mutant or wild-type sequence (although if the affected amino acid plays unequal roles in the two half-sites, they may be partially complementing). This reasoning formed the basis for the heterodimer complementation experiments that we used to create a functional map of one asymmetric binding site on the surface of the symmetric coat protein dimer (8). This map shows striking similarity to one derived from x-ray crystallographic analysis of the coat protein-RNA complex and allows a fairly complete correlation of the results of structural and genetic analyses.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 5.   Illustrations showing the effects on the RNA-binding site of combining mutant and/or wild-type sequences in single-chain coat protein heterodimers. Asterisks indicate mutational inactivation of a half-site. A, a wild-type homodimer. B, mutant homodimer in which mutation has inactivated half-site A in the picture at left, or half-site B in the picture on the right. C, a wild-type-mutant heterodimer. D, a mutant heterodimer in which the two monomers have mutations in different half-sites.

We wanted to determine whether Thr45 could be assigned by this method to one of the half-sites. The crystal structure tells us that A-4 and A-10 are bound on different subunits of the dimer and, further, it identifies the genetically defined half-sites to which they are bound (8). Therefore, pairing a Thr45 mutation with ones previously assigned to one or the other half-site should make it possible to determine whether the primary role of Thr45 is in binding A-4 or A-10. From the experiments described above, we knew that some Thr45 mutants could be complemented by the wild-type sequence in single-chain heterodimers. We decided to create heterodimer constructs in which T45A was paired with Y85H or N87S, which were previously mapped to half-site A (the position of A-4 contact), and with N55D and T91I from half-site B (where A-10 is bound). These mutants were chosen for the complementation studies because their roles in RNA binding are fairly well defined by both structural and genetic analyses. The ring of TyrA85 stacks on U-5, and its hydroxyl group H-bonds to the phosphate of the same nucleotide. The side chain amide of AsnA87 forms an H-bond to O2 of U-5. AsnB55 interacts with the phosphate of A-7. ThrB91 does not appear to contact RNA, and its substitution in the T91I mutant apparently inactivates the RNA-binding site by steric interference in half-site B. T45A was paired with these mutants to produce the single-chain heterodimers listed in Table III.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Complementation of T45A in heterodimers with wild-type N55D, Y85H, N87S, or T91I
The numbers represent percentages of the beta -galactosidase activity produced in the unrepressed state.

Agarose gel electrophoresis showed that each of the heterodimers was competent for capsid assembly, indicating that all are properly folded (results not shown). The RNA-binding activities of the various heterodimers were tested by comparing their abilities to repress beta -galactosidase synthesis in bacteria containing the plasmid pRZ5. Table III compares the beta -galactosidase activities of bacteria with the indicated heterodimer constructs. T45A is capable of efficient translational repression when paired in heterodimers with N55D or T91I. It complements these mutants as well, or nearly as well, as does a wild-type subunit. But when paired with Y85H or N87S, each of the T45A-containing heterodimers is a poor repressor. This behavior assigns Thr45 to half-site A where it interacts with A-4.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Protein Structure Effects of Thr45 Substitutions-- Even before the determination of the structure of the RNA-protein complex, an important role for Thr45 was suggested by its conservation across an evolutionary spectrum of RNA phage coat proteins. An involvement of Thr45 in RNA binding was strongly indicated when the crystal structure of the RNA-protein complex revealed the presence of quasi-symmetric interactions of the bulged adenosine at -10 and the loop adenosine at -4 with a site containing Val29, Thr45, Ser47, and Lys61 and which is present in both halves of the dimer (11, 12). Therefore, we were surprised by our failure to find substitutions implicating Thr45 as a component of the binding site in our collection of repressor-defective mutants. The results presented here provide an explanation; the structure of coat protein is perturbed by every substitution of residue 45, so that all but a few Thr45 mutants would have been discarded during the screen for capsid assembly. Moreover, those mutants that still produced a significant amount of capsid must have been rare, if not absent, in our mutant library, since only one of them (T45S) could have resulted from a single-nucleotide substitution.

Some other amino acids in the RNA-binding site apparently exhibit a sensitivity to substitution similar to that of Thr45. Recently, we introduced mutations at Val29, Ser47, Thr59, and Lys61, residues also implicated in A-4 and A-10 binding. Ser47 and Thr59 seem to tolerate substitutions, but many different changes at positions 29 and 47 destroyed the ability of the protein to assemble into capsids.2

We find the extreme substitution sensitivity of Thr45 to be surprising, but as our interest is mainly directed toward the RNA-binding site, we have made little effort to characterize the protein structural defects imparted by these mutations. However, several previous studies have systematically examined the effects on protein stability of amino acid changes on the surfaces of beta -sheets. They paint a complicated picture. Statistical analysis of amino acid sequences long ago showed that the various amino acids have different tendencies to appear in beta -structure (20, 21), and some mutational studies have suggested that the rank order of these statistically defined propensities roughly correlates with the protein stability effects of amino acid substitutions (22-24). Threonine is generally near the top of such rankings (22, 23, 25). Effects of substitutions on stability are observed even when pains are taken to eliminate interactions of the mutated amino acid with nearby side chains (22, 25), presumably reflecting the intrinsic tendency of an amino acid to appear in a beta -strand. However, structural context also plays an important role; mutational analyses demonstrate that the rank order of apparent beta -sheet propensities can differ sharply from one protein to another, and even depends on the precise location of an amino acid within the sheet of a single protein (26). The importance of context is also supported by skewing in the frequencies with which certain amino acid pairs are found in neighboring positions on adjacent beta -strands (27, 28), and by the experimental determination of stability effects of pairwise amino acid substitutions (24). Inspecting the local environment of Thr45 shows that its non-H-bonded cross-strand neighbor is Glu31. Hutchinson et al. (28), in a statistical survey of favored residues in beta -sheets, showed that Thr-Glu pairs are often found in such positions.

Effects on RNA Binding-- The crystal structure of the coat protein-RNA complex suggests a key role for Thr45 on both subunits of the coat dimer in stabilizing the RNA-protein complex (11, 12). Specifically it was proposed that ThrA45 H-bonds with N6 and N7 of A-4 and ThrB45 with N1 and N6 of A-10. However, our finding that several substitutions permit normal or near normal translational repression when present in only one half of the dimer suggests that one of the Thr45 residues makes little or no contribution to the energy of RNA binding. Since structural studies implicate the Thr45 hydroxyl group in RNA binding, it was no surprise that serine was a reasonable replacement. In fact, the WT-T45S and T45S-WT recombinants were fully active as translational repressors. However, 2T45S, which contains the serine replacement in both halves of the dimer, did not quite attain wild-type activity, suggesting that the methyl group of one of the threonines must play some role in RNA-binding. This does not imply necessarily that the methyl group participates in interaction with RNA directly. It may simply engage in interactions that favor the correct positioning of the hydroxyl. The complete, or nearly complete, recovery of translational repressor activity by heterodimer constructs in which one wild-type subunit was paired with T45G, T45N, T45C, or T45A adds weight to the argument that the identity of Thr45 is really crucial to RNA binding on only one of the two subunits. Moreover, the pattern of complementation when the T45A mutant is combined with other RNA-binding site mutations in single-chain heterodimers indicates that it is primarily ThrA45's interaction with A-4 that is sensitive to substitution.

These results have at least three possible explanations. (i) ThrB45 interactions with RNA might make only a small contribution to the stability of the RNA-protein complex. Additional support for this idea comes from studies of the effects of nucleotide substitutions of A-10. Wu and Uhlenbeck (29) found that guanine, inosine, and 2-aminopurine were acceptable replacements for the bulged nucleotide. Since these remove the amino group at position C-6 of the base (2-aminopurine) or replace it with a keto group (guanosine or inosine), it seems unlikely that crucial contacts are made at this site. (ii) Some amino acid substitutions might replace lost contacts with new ones. This seems an unlikely alternative. It makes some sense that serine and cysteine should be tolerable replacements of ThrB45, but, despite their rather large structural differences, glycine works as well, and alanine and asparagine work nearly as well as serine and cysteine when combined in heterodimers with a wild-type sequence. (iii) Conformational adjustments may allow the formation of new contacts, which compensate for the loss of H-bond interactions that accompany ThrB45 substitution. This possibility is supported by the x-ray structure of the complex of the T45A mutant with RNA, which reveals RNA conformational changes in the vicinity of both A-4 and A-10 (30). Some of these changes, especially those near A-10, seem to offset partially the loss of normal Thr45 contacts by forming additional favorable contacts at other nearby sites. We wonder whether similar, but more extensive, conformational adjustments accompany the substitution of Thr45 with Gly, offsetting the loss of Thr45 side-chain contacts so completely that the WT-T45G heterodimer is as good a repressor as wild-type.

The coat proteins of different RNA phages bind different hairpins (31). However, they do not appear to have acquired the wide range of specificities that characterizes, for example, the ribonucleoprotein class of proteins (32), which also use a beta -sheet as the RNA binding site. Our results point out two constraints that must limit the ability of RNA phage coat proteins to evolve new RNA binding specificities. First, the stability of coat protein can be highly sensitive to substitution of RNA-binding site amino acids. This limits its ability to adapt to new ligands. Second, because of the two-fold symmetric nature of the coat protein dimer, any change in one half of the RNA-binding site is accompanied automatically by an identical change in the other half. Therefore, it may be difficult for coat protein to acquire new specificities for intrinsically asymmetric RNA ligands. One wonders what new specificities could be conferred to single-chain coat proteins, where the destabilizing effects of amino acid substitutions are better tolerated, and where the RNA-binding site is free to develop asymmetries.

    FOOTNOTES

* This work was supported by a grant from the National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 505-272-0071; Fax: 505-272-9494; E-mail: dpeabody@salud.unm.edu.

2 D. S. Peabody and A. Chakerian, unpublished observations.

    ABBREVIATIONS

The abbreviations used are: X-gal, 5-bromo-4-chloro-3-indolyl-beta -D-galactoside; WT, wild-type.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Valegard, K., Liljas, L., Fridborg, K., and Unge, T. (1990) Nature 345, 36-41[CrossRef][Medline] [Order article via Infotrieve]
2. Golmohammadi, R., Valegard, K., Fridborg, K., and Liljas, L. (1993) J. Mol. Biol. 234, 620-639[CrossRef][Medline] [Order article via Infotrieve]
3. Ni, C.-Z, Syed, R., Kodandapani, R., Wickersham, J., Peabody, D. S., and Ely, K. R. (1995) Structure 3, 255-263[Medline] [Order article via Infotrieve]
4. Borer, P. N., Lin, Y., Wang, S., Roggenbuck, M. W., Gott, J. M., Uhlenbeck, O. C., and Pelczer, I. (1995) Biochemistry 34, 6488-6503[CrossRef][Medline] [Order article via Infotrieve]
5. Romaniuk, P. J., Lowary, P., Wu, H., Stormo, G., and Uhlenbeck, O. C. (1987) Biochemistry 26, 1563-1568[CrossRef][Medline] [Order article via Infotrieve]
6. Peabody, D. S. (1990) J. Biol. Chem. 265, 5684-5689[Abstract/Free Full Text]
7. Peabody, D. S. (1993) EMBO J. 12, 595-600[Medline] [Order article via Infotrieve]
8. Peabody, D. S., and Lim, F. (1996) Nucleic Acids Res. 24, 2352-2359[Abstract/Free Full Text]
9. Lim, F., Spingola, M., and Peabody, D. S. (1994) J. Biol. Chem. 269, 9006-9010[Abstract/Free Full Text]
10. Lim, F., Spingola, M., and Peabody, D. S. (1996) J. Biol. Chem. 271, 31839-31845[Abstract/Free Full Text]
11. Valegard, K., Murray, J. B., Stockley, P. G., Stonehouse, N., and Liljas, L. (1994) Nature 371, 623-625[CrossRef][Medline] [Order article via Infotrieve]
12. Valegard, K., Murray, J. B., Stonehouse, N. J., van den Worm, S., Stockley, P. G., and Liljas, L. (1997) J. Mol. Biol. 270, 724-738[CrossRef][Medline] [Order article via Infotrieve]
13. Kunkel, T. A., Roberts, J. D., and Zakour, R. A. (1987) Methods Enzymol. 154, 367-382[Medline] [Order article via Infotrieve]
14. Miller, J. H. (1972) Experiments in Molecular Genetics , pp. 352-355, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
15. Laemmli, U. K. (1970) Nature 227, 680-685[CrossRef][Medline] [Order article via Infotrieve]
16. Burnette, W. N. (1981) Anal. Biochem. 112, 195-203[CrossRef][Medline] [Order article via Infotrieve]
17. Draper, D. E., White, S. A., and Kean, J. M. (1988) Methods Enzymol. 164, 221-237[Medline] [Order article via Infotrieve]
18. Carey, J., Cameron, V., de Haseth, P. L., and Uhlenbeck, O. C. (1983) Biochemistry 22, 2601-2610[CrossRef][Medline] [Order article via Infotrieve]
19. Peabody, D. S. (1997) Arch. Biochem. Biophys. 347, 85-92[CrossRef][Medline] [Order article via Infotrieve]
20. Chou, P. Y., and Fasman, G. D. (1974) Biochemistry 13, 211-222[CrossRef][Medline] [Order article via Infotrieve]
21. Chou, P. Y., and Fasman, G. D. (1978) Mol. Biol. 47, 45-148
22. Minor, D. L., and Kim, P. S. (1994) Nature 367, 660-663[CrossRef][Medline] [Order article via Infotrieve]
23. Kim, C. A., and Berg, J. M. (1993) Nature 362, 267-270[CrossRef][Medline] [Order article via Infotrieve]
24. Smith, C. K., and Regan, L. (1995) Science 270, 980-982[Abstract/Free Full Text]
25. Smith, C. K., Withka, J. M., and Regan, L. (1994) Biochemistry 33, 5510-5517[CrossRef][Medline] [Order article via Infotrieve]
26. Minor, D. L., and Kim, P. S. (1994) Nature 371, 264-267[CrossRef][Medline] [Order article via Infotrieve]
27. Lifson, S., and Sander, S. (1980) J. Mol. Biol. 139, 627-639[CrossRef][Medline] [Order article via Infotrieve]
28. Hutchinson, E. G., Sessions, R. B., Thornton, J. M., and Woolfson, D. N. (1998) Protein Sci. 7, 2287-2300[Abstract]
29. Wu, H.-N., and Uhlenbeck, O. C. (1987) Biochemistry 26, 8221-8227[CrossRef][Medline] [Order article via Infotrieve]
30. van den Worm, S. H. E., Stonehouse, N. J., Valegard, K., Murray, J. B., Walton, C., Fridborg, K., Stockley, P. G., and Liljas, L. (1998) Nucleic Acids Res. 26, 1345-1351[Abstract/Free Full Text]
31. van Duin, J. (1988) in The Bacteriophages (Calendar, R., ed) , pp. 117-161, Plenum Press, New York
32. Kenan, D. J., Query, C. C., and Keene, J. D. (1991) Trends Biochem. Sci. 16, 214-220[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peabody, D. S.
Right arrow Articles by Chakerian, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peabody, D. S.
Right arrow Articles by Chakerian, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.